Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 16, 2026
TickeronGET DAILY SIGNALS
Cerebras Systems (CBRS): Wafer-Scale AI Hardware and the Case for Investors

Cerebras Systems (CBRS): Wafer-Scale AI Hardware and the Case for Investors

Key Takeaways

  • Cerebras Systems (CBRS) is an artificial intelligence (AI) infrastructure company that designs specialized computing systems for AI training and inference.
  • The company is best known for its Wafer-Scale Engine, an unusually large processor built on a single silicon wafer that aims to outperform traditional graphics processing units (GPUs) for demanding AI workloads.
  • Cerebras is headquartered in Sunnyvale, California, and completed its initial public offering (IPO) on the Nasdaq in 2026.
  • The company generates revenue primarily from selling its AI compute systems to hyperscalers, enterprises, and government and research customers.
  • As a fast-growing but still unprofitable company, Cerebras carries significant execution, competition, and customer-concentration risks.

Company Background

Cerebras Systems focuses on building specialized hardware and software to handle the heaviest AI workloads. Instead of relying on clusters of smaller chips, the company developed a single, wafer-sized processor that it claims can deliver better performance and efficiency than standard GPUs for training large models and running inference. I follow CBRS closely because it operates right in the middle of the surging demand for AI computing capacity, going up against much larger semiconductor names.

Overview and History

Founded to address the growing need for faster AI hardware, Cerebras is based in Sunnyvale, California, and operates in the semiconductor space. Co-founder and CEO Andrew Feldman leads a team with deep experience in high-performance computing. The company went public on Nasdaq under the ticker CBRS in May 2026. Its systems are designed for data-center use, from single racks to large-scale clusters, and can be deployed on-premises or accessed via the cloud.

Core Technology and Business Model

The centerpiece of Cerebras’s approach is the Wafer-Scale Engine (WSE). Traditional manufacturing cuts wafers into many small chips, but Cerebras keeps nearly the entire wafer as one massive processor to cut down on communication delays between separate GPUs. These processors come as complete systems that include cooling, supporting hardware, and software. Revenue comes mainly from selling these integrated AI compute systems and from cloud access to the capacity. Customers range from hyperscalers and large enterprises to government agencies and research institutions.

Market Position and Competition

Cerebras competes in a tough field led by NVDA (NVIDIA) and other players such as AMD. The wafer-scale design is positioned as offering speed and efficiency gains for very large models and inference workloads. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Financially, the company shows rapid revenue growth but remains unprofitable, with heavy spending on research and expansion. Investors tend to watch revenue trends, gross margins, and the pace of commercial adoption rather than traditional profit metrics.

Why Investors Track CBRS

Interest centers on the broad expansion of AI, where larger models drive demand for specialized hardware. Cerebras’s architecture stands out as one of the few commercial alternatives aimed at the high-performance end. The company’s ability to support both on-premises and cloud deployments adds flexibility, while its emphasis on inference aligns with the shift toward production use of AI models. From what I see, progress on customer relationships and converting design wins into recurring revenue will be key watch points.

Risks to Consider

Several factors warrant caution. Cerebras faces much larger rivals with established ecosystems and deeper resources. It continues to report net losses and must fund ongoing development while scaling operations. Customer concentration adds another layer of risk, as a handful of large buyers can represent a significant portion of revenue. Supply-chain issues, geopolitical tensions in semiconductors, and fast-moving technology changes are also relevant. With a limited public track record since the 2026 IPO, the available history for evaluation is shorter than for more established names.

Using Tickeron’s AI Tools for Research

When analyzing names like CBRS, I often turn to Tickeron’s AI-powered platforms to cross-check signals and compare opportunities across the market. The AI Screener, in particular, helps filter thousands of stocks by technical indicators, fundamentals, and AI-generated insights, which can surface ideas that align with a specific strategy. It has become a regular part of how I narrow down research efficiently.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CBRS

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


CBRS in -16.47% downward trend, sliding for three consecutive days on November 05, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CBRS declined for three days, in 28 of 28 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for CBRS entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 5 of 5 cases where CBRS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Moving Average Convergence Divergence (MACD) for CBRS just turned positive on November 09, 2026. Looking at past instances where CBRS's MACD turned positive, the stock continued to rise in 1 of 2 cases over the following month. The odds of a continued upward trend are 50%.

Following a +18.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBRS advanced for three days, in 17 of 22 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

CBRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.327) is normal, around the industry mean (5.443). P/E Ratio (-19.264) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (63.694) is also within normal values, averaging (46.468).

The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. CBRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), QUALCOMM (NASDAQ:QCOM), Analog Devices (NASDAQ:ADI), Marvell Technology (NASDAQ:MRVL).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 180.14B. The market cap for tickers in the group ranges from 86.8K to 4.51T. NVDA holds the highest valuation in this group at 4.51T. The lowest valued company is STRB at 86.8K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was 7%. For the same Industry, the average monthly price growth was -12%, and the average quarterly price growth was -30%. AMBQ experienced the highest price growth at 23%, while NVDA experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was -1%. For the same stocks of the Industry, the average monthly volume growth was 29% and the average quarterly volume growth was -43%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 52
Price Growth Rating: 61
SMR Rating: 72
Profit Risk Rating: 79
Seasonality Score: 20 (-100 ... +100)
AI Screener 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Semiconductors

Industry
N/A
Address
1237 E. Arques Avenue
Phone
+1 650 933-4980
Employees
401
Web
https://www.cerebras.ai
Interact to see
Advertisement
The central price target used here is $400 , roughly 35% above Alphabet's latest verified closing price of $295.77 (November 13, 2026). This target is the arithmetic mean of verified analyst price targets reviewed, not a single analyst's forecast; independent data providers report comparable consensus averages in the high-$390s to low-$400s.
Upcoming catalysts: Integration of advertising into AI Overviews and Gemini conversations, the scaling of Gemini 3 and newer models across Search and Cloud, and the commercial ramp of the $32 billion Wiz cloud-security acquisition could all shape sentiment into 2026. Strategic positioning: Alphabet's vertically integrated artificial intelligence (AI) stack — from custom TPU (Tensor Processing Unit) chips to the Gemini models to Google Cloud — supports a durable, cost-advantaged position in the AI build-out.
The TETH exchange-traded fund (ETF) is the 21Shares Ethereum Staking ETF, a spot Ethereum fund listed on Cboe BZX, and it does not carry conventional analyst price targets. The $14 objective used here is a technical milestone discussed in public market commentary — roughly the zone where Ethereum could begin confirming a recovery — not an analyst consensus.
The central target of $6.70 is the arithmetic mean of seven recent, individually verified analyst price targets, rounded from $6.67. At a latest price near $3.70, reaching $6.70 would require roughly 81% upside — a very large move.
Lead catalyst: Chemomab has secured alignment with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) on a single Phase 3 registration trial for nebokitug in primary sclerosing cholangitis (PSC), a rare liver disease with no approved disease-modifying therapy. Strategic pivot: A planned merger with Scipher Medicine is expected to close by year-end 2026, extending nebokitug into an AI-powered, precision-medicine Phase 2 trial in rheumatoid arthritis (RA).